Type I interferons are cytokines which activate an anti-viral response by binding to two speci®c cell surface receptors, ifnar1 and ifnar2. Here, we report puri®cation and refolding of the extracellular part of human ifnar2 (ifnar2-EC) expressed in Escherichia coli and its characterization with respect to its interaction with interferon a2 (IFNa2). The 25 kDa, non-glycosylated ifnar2-EC is a stable, fully active protein, which inhibits antiviral activity of IFNa2. The stoichiometry of binding IFNa2 is 1:1, as determined by gel ®ltration, chemical cross-linking and solid-phase detection. The af®nity of this interaction is 10 nM, which is similar to the af®-nity measured for the cell surface-bound ifnar2 receptor. No difference in af®nity was found throughout various assays using optical detection as BIAcore or re¯ectometric interference spectorscopy. However, the binding kinetics as measured in homogeneous phase by¯uorescence dequenching was about three times faster than that measured on a sensor surface. The rate of complex formation is relatively high compared to other cytokine-receptor interactions. The salt dependence of the association kinetics suggest a limited but signi®cant contribution of electrostatic forces towards the rate of complex formation. The dissociation constant increases with decreasing pH according to the protonation of a base with a pK a of 6.7. The surface properties of the IFNa2 binding surface on ifnar2 were interpreted according to the pH and salt dependence of the interaction.
Introduction
Interferons are cytokines initially characterized by their potent anti-viral activity. Human type I interferons include a large family of about 13 different IFNa functional non-allelic genes (with 70 % homology between them), a single gene encoding for IFNb (35 % homology to IFNa) as well as IFNo and t. Two cellular receptors are involved in binding all type I interferons, ifnar1 (Uze Á et al., 1990) and ifnar2 (Novick et al., 1994) . Mutagenesis studies have suggested that the binding site for each of the two receptors is located at a different part of the interferon molecule (Uze Á et al., 1995) . Upon binding, interferon causes the two receptors to associate, with interferon bridging them together (Cohen et al., 1995) . In addition to ifnar1 and ifnar2, their associated intracellular tyrosine kinases (Tyk2 and Jak1) are also required for the productive presentation of the binding site (Uze Á et al., 1995) . Three molecular forms of ifnar2 are generated by alternative splicing: a soluble secreted protein and two transmembrane forms. All three have identical extracellular (EC) domains (Domanski et al., 1995; Novick et al., 1994) . The binding af®nity of the ternary ifnar1-ifnar2-IFNa2 complex is in the numomolara range, with ifnar2 alone binding IFNa2 at a ®ve-to tenfold lower af®-nity (Cohen et al., 1995; Cutrone & Langer, 1997) . ifnar1 alone does not seem to be able to bind either IFNa2 or IFNb at a detectable level (Cohen et al., 1995; Cutrone & Langer, 1997; Langer et al., 1998) . No structures are available for ifnar1 or ifnar2, but it is possible to model ifnar2 according to its homology to the known structures of TF receptor, HGH-R and IFN-g-R (Lewerenz et al., 1998) .
However, one has to be cautious regarding to the accuracy of the model, as the homology between these proteins is below 25 %, with the lowest homology being near the suggested binding site of interferon on ifnar2, which was determined by mutagenesis studies (Lewerenz et al., 1998) .
A detailed understanding of the protein-protein interactions which initiate the interferon signaling pathway requires accurate structural information. For such investigations, large amounts of pure and active protein are required. The ability to express proteins heterologously in Escherichia coli had a big impact on the study of structure-function relation on a number of other cytokines, as for example HGH-receptor (de Vos et al., 1992) , TF-receptor (Harlos et al., 1994) and interferon-g-receptor interactions (Walter et al., 1995) . All those three receptor molecules are cell surface glycoproteins (as is ifnar2). Still, their binding activity and structure does not seem to be affected by the loss of glycosylation upon expression in E. coli.
Here, we describe for the ®rst time the successful refolding and puri®cation of the extracellular domain of ifnar2 (ifnar2-EC) expressed in E. coli, and its characterization in terms of its ability to bind interferon. We assessed the kinetics and thermodynamics of this interaction using biological and biophysical methods, including anti-viral protection cell assays, analytical gel ®ltration, optical heterogeneous phase detection and¯uorescence spectroscopy. We show that the non-glycosilated extracellular portion of ifnar2 is a soluble protein, which retains the ability to bind IFNa2 with a 1:1 stoichiometry with the same af®nity as the natural cell surface receptor.
Results
The extracellular domain of ifnar2 (ifnar2-EC) and IFNa2 were expressed in E. coli under the control of a T7 promoter in a modi®ed pT7T318U vector, to which we added a two-cistron translational initiation site. The advantage of this expression system is that it eliminates problems related to translational activation of heterologous expression in E. coli without the use of a fusion-protein. The use of this vector improved the otherwise poor expression of ifnar2-EC (Figure 1, lane 1) . All ifnar2-EC protein precipitated in the form of inclusion bodies (lanes 2 and 3) which were solubilized in 8 M urea. SDS-PAGE analysis under non-reducing conditions (lane 4) revealed that about 50 % of the protein were monomeric, while the rest formed multimeric, disul®de-linked aggregates. Refolding was initiated by a 20-fold dilution. The monomeric fraction of ifnar2-EC was extracted from this solution by batch ion exchange chromatography. Further puri®cation by column ionexchange was necessary to remove other species of ifnar2-EC, which were monomeric, but inactive, as well as other proteins (lane 5 and 6). After gel ®ltration chromatography, ifnar2-EC was puri®ed to at least 95 % homogeneity (lane 7). Typical protein yields were 2.5 mg/l cell culture. A single, sharp band at 25 kDa was observed in SDS-PAGE both under reducing and non-reducing conditions (cf. Figure 4 , lane 2). N-terminal sequencing of ifnar2-EC showed that the protein starts at residues SYDSP, in agreement with the expected sequence. The protein sequencing assay also con®rmed a level of puri®cation of at least 95 %. Ellman assays under native and denaturing conditions clearly proved that properly folded ifnar2-EC does not contain free cysteine residues. Hence, three disul®de bonds are formed in the mature protein.
Anti-viral and neutralization activity of recombinant IFNa a a2 and ifnar2-EC An antiviral activity of 8 Â 10 8 units/mg was measured by a cytopathic effect inhibition assay in human WISH cells for the E. coli-produced IFNa2, using NIH IFNb as a standard. This is in the typical range found for IFNa2 from other sources. A 50 % inhibition of the activity of 25 units/ml (1.6 Â 10 À12 M) of IFNa2 was observed with 10 nM ifnar2-EC. Concentrations of ifnar2-EC higher than 100 nM completely inhibited the activity of IFNa2 in this assay. A dissociation constant of 1.1 Â 10
À8
M for the interaction between ifnar2-EC and IFNa2 was determined by ®tting equation (1) to the residual IFNa2 activity upon titration with ifnar2-EC (Figure 2 ).
Stoichiometry of ifnar2-EC-IFNa a a2 binding
Analytical size-exclusion chromatography was used to evaluate the fraction of active protein as well as to determine the stoichiometry of the complex. Figure 3(a) shows the chromatograms of IFNa2, ifnar2-EC and the complex formed by these two proteins at different concentrations. On this column (Superdex R 75 HR10/30), free IFNa2 eluted at a volume of 12 ml, ifnar2-EC at 10.8 ml and the complex of the two at 9.8 ml. Keeping the concentration of ifnar2-EC constant and increasing the relative concentration of IFNa2 resulted in a diminishing peak of the non-bound ifnar2-EC, while the peak of the complex increased. The peak representing the complex reached its maximum at a 1:1 stoichiometry of IFNa2:ifnar2-EC, and did not further increase upon increasing the quantity of IFNa2. At excess IFNa2, a further peak appeared, which corresponds to the non-bound protein. A quantitative analysis of the area under the three peaks clearly shows that the stoichiometry of the complex observed under these conditions is 1:1 (Figure 3(b) ). Molecular mass standards further corroborated the size of the complex (data not shown). A stoichimetric excess of one of the proteins resulted in a complete disappearance of the peak of the other protein, supporting the evidence that both IFNa2 and ifnar2-EC were more than 95 % active. No dissociation of the complex was observed during the run in the column. The protein concentration in the column was about 100-200 nM, supporting the evidence that the af®nity between the two proteins is at least in the lower nanomolar range.
Further validation of the 1:1 stoichiometry of the interaction between IFNa2 and ifnar2-EC in mM concentration was obtained by zero-length crosslinking of the two proteins. The analysis of the cross-linked species by SDS-PAGE are shown in Figure 4 . The non-cross-linked complex (lane 3)
shows the two bands of IFNa2 (lane 1) and ifnar2-EC (lane 2). Upon adding the cross-linking reagent (EDC) to IFNa2 (lane 4) or to ifnar2-EC (lane 5) no changes were detected. However, when applying the reagent to the complex, an additional species of the size of 45 kDa appeared (lane 6). This size exactly corresponds to the sum of the molecular mass of IFNa2 and ifnar2-EC. No other species were detected for this cross-linking method.
Characterization of the IFNa a a2-ifnar2-EC interaction with optical biosensor systems Investigation of the interaction of proteins by label-free solid phase detection such as surface plasmon resonance (SPR) or re¯ectometric interference spectroscopy (RIfS) requires the immobilization of one of the interacting compounds. We Analysis of IFN2-Ifnar2 Complex have employed both of these techniques using covalent immobilization of both IFNa2 and ifnar2-EC via free amine groups into a carboxylated dextran layer. Most of the investigations were carried out by RIfS, with the results corresponding very well to results obtained by SPR on a BIAcore2000. All results are summarized in Table 1 .
IFNa2 reacted readily with the activated surface leading to irreversible attachment of approximately 50 % of the pre-concentrated protein within 400 seonds. Subsequent injections of ifnar2-EC in various concentration revealed that typically 30 % of the bound IFNa2 was active, i.e. can bind ifnar2-EC. The immobilized protein was stable at room temperature for several days (20 % loss of activity per day), without signi®cant loss of activity when treated with 100 mM HCl. Binding of ifnar2-EC ( Figure 5 ) to the immobilized IFNa2 was clearly speci®c and was completely inhibited when adding an excess of free IFNa2. The dissociation of the complex at the surface was ®tted by a single exponential decay, with the residuals of the ®t distributed randomly around zero. At pH 7.4 and 150 mM NaCl, a mean dissociation rate constant k off of 0.035 (AE0.003) s À1 was consistently observed, independent on the time range used for ®tting. The value of k off is constant between pH 7.4 and 9, but increases rapidly at lower pH values ( Figure 6 ) down to approximately 0.1 s À1 at pH 5.5. A pK a value of 6.7 was determined from this dependency by ®tting a model that assumed two distinct dissociation rate constants for the two differently charged states of the protein interface.
Several problems where encountered during the evaluation of the binding of ifnar2-EC to immobilized IFNa2. (i) The association phase deviates signi®cantly from a ®rst-order kinetic model. Therefore, only the ®rst 25 seconds of the binding curve could be used to extract the association rate constant. (ii) The values of the association rate constants decreased with ligand concentration. As a result the observed rate of association (k s ) did not show a linear dependence on ligand concentration (Figure 7 (a)). (iii) The equilibrium surface loading R eq is not a hyperbolic function of the concentration, which is revealed by the non-linearity of All measurements were performed in 50 mM Hepes (pH 7.4) and 150 mM NaCl. In heterogeneous phase one of the proteins was bound to the sensor surface, while in homogeneous phase both proteins were in solution. Af®nity constants in homogeneous phase were determined by equilibrium titration in solution using the immobilized protein to probe the equilibrium free concentration of the other protein . Numbers in parenthesis are either the standard deviations (s) determined from at least ®ve repeated measurements or the standard errors determined from a curve ®t of at least ®ve independent measurements. a K d is calculated from k off /k on measured in heterogeneous phase. the Scatchard-plot (Figure 7 (b)). Therefore, no consistent af®nity information can be extracted by this method. ifnar2-EC reacted with a high degree of ef®-ciency with the surface, but speci®c activity was only 5-10 % of the total surface loading. The ifnar2-EC bound to the surface was loosing about 50 % of its activity per day and 100 % activity upon treatment with 100 mM HCl. Nevertheless, speci®c binding of IFNa2 to immobilized ifnar2-EC was clearly detectable with a typical maximum surface loading R max of 100-150 pm (100 -150 pg/mm 2 ).
This corresponds to a surface concentration of active ifnar2-EC of 5-10 pmol/mm 2 . Dissociation followed a single exponential kinetics leading to a dissociation rate constant of 0.022 s
À1
, which is about 30 % lower than that observed for the immobilized IFNa2. However, the association phase of the binding curve gave consistent results in this constellation. No systematic deviations from the pseudo-®rst-order kinetics model were observed, with an average association rate constant of 2.3 Â 10 6 M À1 s À1 for all IFNa2 concentrations. The plot of the observed association rate k s versus the concentration (Figure 7(a) ) gave a linear correlation. The rate constants determined by linear regression were in excellent agreement with the rate constants determined from the individual curves (Table 1) . A dissociation constant K d of Figure 6 . pH dependence of the dissociation rate constant of ifnar2-EC and IFNa2 measured by RIfS. The line corresponds to a model that was ®t to the data assuming a distinct dissociation rate constant for each of two states of ionization. (a) Observed rate constant k s versus the concentration; (b) Scatchard-plot determined from the equilibrium surface loading observed for immobilized IFNa2 and ifnar2-EC. For comparison, the equilibrium surface loading R eq is normalized by the maximum surface loading R max .
Analysis of IFN2-Ifnar2 Complex 10 nM was obtained from these rate constants assuming K d k off /k on . Evaluation of the equilibrium response in a Scatchard-plot gave a single dissociation constant of 12.5 nM (Figure 7(b) ). The values from all these evaluation methods including their errors are compared in Table 1 . As this is the ®rst time that RIfS technology was used to monitor interactions with covalently attached proteins, we validated this data by comparing them with data obtained in similar conditions using a BIAcore 2000 with a standard CM5 chip. No signi®cant differences (2s criterion, a 0.95) were found between the rate constants measured with RIfS versus the BIAcore (Table 1) .
Heterogeneous phase detection can also be used for determining af®nity constants in solution by a binding inhibition assay . The principle of this method is similar to the inhibition assay of anti-viral activity of IFNa2. In both cases, the equilibrium concentration of free protein in solution is detected by its binding to the immobilized protein, either on the cell surface or on the transducer surface. We used this approach for characterizing the interaction between IFNa2 and ifnar2-EC by immobilizing IFNa2 to the surface, and titrating ifnar2-EC in solution with increasing concentrations of IFNa2. Concentration of free ifnar2-EC was determined from the residual binding to the immobilized IFNa2. The titration curves obtained for two ifnar2-EC concentrations are shown in Figure 2 . By ®tting the accurate binding model obtained from the law of mass action (equation (2)) to the data, a dissociation constant K d of 10 nM was obtained for both concentrations.
Interaction kinetics in solution
Fluorescence spectra of the free proteins and of the complex at an excitation wavelength of 280 nm revealed that de-quenching of tryptophane¯uor-escence occurs upon binding (data not shown). Dequenching of the¯uorescence allowed measurement of the association rate constant in solution using a stopped-¯ow technique. Under pseudo®rst-order conditions, an association rate constant of 7 Â 10 6 M À1 s À1 was determined for complex formation in 150 mM NaCl at pH 7.4 (Figure 8(a) ). This is three times higher than the association rate constant measured at the solid-liquid interface with immobilized ifnar2-EC. Assuming that under the experimental conditions no intermediate accumulates during the association reaction, the dissociation rate constant in solution is 0.07 s
À1
. The contribution of electrostatic steering can be estimated from the electrostatic energy of interaction of the two proteins in the transition state (U el ). Analyzing the dependence of the association rate constant on salt concentration revealed a linear relation between lnk on and (1 ka) À1 (Figure 8(b) ). Linear regression gave a slope of 4, which is a measure of the electrostatic energy contribution U el /RT to the association rate constant. The basal association rate constant in the absence of electrostatic forces is 8 Â 10 5 M À1 s À1 as determined from the intercept of the plot (in®nite ionic strength).
Discussion
A prerequisite for biophysical studies of proteins is the ability to express, refold and purify them in large quantities while retaining the activity of the original proteins. Here, we have described refolding, puri®cation and extensive characterization of the extracellular part of the human type I interferon receptor ifnar2 (ifnar2-EC) expressed in E. coli. Recombinant ifnar2-EC was found to be a very stable protein with all cysteine residues forming intra-molecular disul®de bonds. Its activity as an inhibitor of type I interferons is similar to the original p40 ifnar2- , where k is the inverse of the Debye-length and a is the minimal distance of approach set to 6 A Ê . The slope of the curve gives the electrostatic energy contribution U el /RT of the association reaction.
EC puri®ed from human urine (Novick et al., 1994) . Applying the 2s criterion (a 0.95), the binding af®nity of 10 nM to IFNa2 was found consistently throughout various assays. This dissociation constant does not signi®cantly differ from those reported for cell surface-bound and soluble human ifnar2 (Cohen et al., 1995; Cutrone & Langer, 1997) . From these results we conclude that the non-glycosylated ifnar2-EC described in this study has essentially retained its biological activity and can be used for further biophysical investigations of the type I interferon receptor. This is not surprising, as several other extracellular domains of cytokine receptors have been expressed successfully in E. coli (Bignon et al., 1994; Cacaccia et al., 1993; Fuh et al., 1990) .
Ifnar2-EC was puri®ed from the inclusion bodies of E. coli. However, we found that for about 50 % of the total ifnar2-EC only intra-molecular disul®de bonds were formed. A total of 70 % of this protein refolded into fully active ifnar2-EC, with the three disul®de bonds correctly formed. The remaining 50 % ifnar2-EC formed disul®de linked, high molecular mass aggregates. The ratio of correctly formed disul®de bonds in the inclusion bodies is surprisingly high. Random formation of three correct disul®de bonds from an unfolded polypeptide chain is highly unlikely: we never found conditions to re-form the disul®de bonds in vitro after reduction. Oxidation of reduced ifnar2-EC always resulted in the formation of high molecular mass aggregates. We suggest that the protein was already properly folded in the reducing environment of the E. coli cytosol, prior to aggregation in inclusion bodies. This phenomenon has already been observed in our laboratory for the overexpression of BLIP (b-lactamase inhibitor protein) in E.coli (Albeck & Schreiber, 1999) . Ellman assays con®rmed that all six cysteine residues of ifnar2-EC form intramolecular disul®de bonds. Homology modeling based on tissue factor receptor suggests that the three disul®de bonds are between the cysteine residues 12:95, 58:66 and 178:200.
The interaction between ifnar2-EC and IFNa2 was analyzed both in homogeneous phase and at the solid-liquid interface by a variety of methods. The stoichiometry of binding in homogeneous phase was measured to be 1:1 for IFNa2 as determined from gel-®ltration (100 nM concentrations) and chemical cross-linking (lower micromolar concentration). These results do not exclude the possibility that at higher concentrations weak interactions can lead to complexes of different stoichiometries. Surface-bound proteins can cluster to very high local concentrations. Heterogeneous phase detection mimics such conditions, allowing for real-time monitoring of binding. Here we immobilized ifnar2-EC (or IFNa2) to a very¯exible dextran layer which would allow interaction of more than one ifnar2-EC with IFNa2 (as has been observed for human growth hormone binding to immobilized receptor; Cunningham & Wells, 1993) . The ifnar2-EC concentration in the dextran layer is 5-10 pmol/mm 2 , which corresponds to a receptor density of about 50000 per cell. Still, single-phase association and dissociation kinetics were observed at all surface loadings, and ligand concentrations, extending over the whole amplitude. Multiplephasic association and dissociation curves are frequently seen when monitoring surface binding, and their interpretation needs caution because of experimental artifacts. This is not the case when only a single phase is observed. This can be interpreted as a single process occurring, which suggests a 1:1 stoichiometry for the interaction of IFNa2 with ifnar2-EC.
Heterogeneous phase detection offers a variety of approaches to characterize the kinetics and thermodynamics of binding. Still one has to view the results critically. Here we compare interaction parameters determined from immobilized IFNa2 or ifnar2-EC with measurements in homogeneous phase. Upon immobilization of IFNa2, singlephase dissociation kinetics with a uniform rate constant for all protein concentrations was observed. However, determined values of association rate constants and af®nity varied with concentration. These results could be explained by the nonspeci®c immobilization procedure, which may had affected the binding site of the immobilized IFNa2, leading to different interaction properties. However, because of the fast, single-phase dissociation kinetics, we tend to ascribe the reduced and inconsistent association kinetics of ifnar2-EC to the considerable electrostatic repulsion of ifnar2-EC (net charge of À13) by the negatively charged dextran layer in which IFNa2 is immobilized. A very similar phenomenon has been observed in our laboratory for the association of the negatively charged TEM-1-b-lactamase to immobilized BLIP (Albeck & Schreiber, 1999) .
Binding of IFNa2 to immobilized ifnar2-EC gave consistent values of rate constants and af®nity, independent on concentration. The same binding af®nity was determined for IFNa2 binding to immobilized ifnar2-EC, as for complex formation in solution. Still, the association rate constant was three times lower with ifnar2-EC immobilized to the surface, compared to stopped-¯ow measurements in the homogeneous phase. This indicates that the dynamics of the interaction is affected by the immobilization of ifnar2-EC without affecting the free energy of the complex formation. This phenomenon has been frequently observed for solid phase detection of protein-protein interactions and has been ascribed to a variety of reasons. However, in case of a membrane anchored receptor like ifnar2, the kinetics obtained by solid phase detection may even more authentically re¯ect the biological processes on the cell surface.
The rate constants of association and dissociation between ifnar2-EC and IFNa2 are relatively high compared to other cytokine receptor interactions, as for example IL-4-receptor (k on 1. Toniatti et al., 1996) . The fast interaction dynamics could play an important role in signal transduction, as this means that the complex between IFNa2 and ifnar2 is short living, while retaining relative high af®nity. This gives only a limited time for ifnar1 to associate into the active ternary complex. Fast transient kinetics also has methodological implications, because indirect af®nity assays like binding inhibition and sequential solid phase detection can be strongly affected by fast dissociation. Therefore, monitoring of the interaction by¯uorescence dequenching and real-time BIA is much more reliable for an accurate assessment of af®nity. This becomes particular important for characterizing mutants, which are expected to have even higher dissociation rate constants.
The dependence of the interaction kinetics on ion strength and on the pH provides some insight into the properties of IFNa2 binding site of ifnar2. Electrostatic steering plays an important role in fast association of protein complexes (Schreiber & Fersht, 1996) . It is generally found that the binding sites of two fast associating proteins are complementary charged. As the binding site of ifnar2 on IFNa2 is positively charged (Radhakrishnan et al., 1996) and the surface of ifnar2-EC is strongly negatively charged, such electrostatic rate enhancement can be expected. However, the dependence of the association rate constant on the salt concentration revealed a rather high basal rate constant and only modest electrostatic enhancement. Thus, electrostatic forces play only a limited role in determining the rate of association for this complex, suggesting that the interferon binding site on ifnar2 is not at a negatively charged hot spot on the protein surface. This compares favorable with the electrostatic potential at the binding site of interferon on an ifnar2 structural model, as suggested from mutagenesis studies (Lewerenz et al., 1998 ; J.P. & G. S., unpublished data). It will be interesting to see how electrostatic steering affects the association rate of other type I interferons to ifnar2.
The pH dependence of the dissociation rate constant attests the involvement of at least one histidine residue in the interaction between ifnar2-EC and IFNa2 with a pK a of 6.7 in the complex. The rate of dissociation at pH 5.5 is nearly three times faster than at physiological pH, indicating lower af®nity in case of a protonated, positively charged histidine residue. At least two histidine residues are located within the binding interface, one is His34 in IFNa2 (Radhakrishnan et al., 1996) , and the other is His103 in ifnar2 (Lewerenz et al., 1998) . The lower af®nity of the protonated species indicates a downshift of the pK a in the complex compared to the free species. Hence, the pK a of the histidine residue in the free protein is even higher than 6.7 and strongly up-shifted compared to the pK a of a free histidine residue (6.3). This requires a negatively charged local environment (Loewenthal et al., 1993) and therefore indicates that this histidine residue is on the ifnar2-EC surface. The tight pH dependence of the dissociation rate constant could be of biological signi®cance and remains to be investigated more thoroughly.
The long-term goal of our investigations is a detailed understanding of the recognition of type I interferons by its receptor on the molecular level to decipher its structure-activity relationship. With the work presented in this study, we believe to have established a very solid and promising bases for this project: (i) an ef®cient procedure for preparation and puri®cation of ifnar2-EC in large quantities which are required for crystallization and for investigations by NMR; and (ii) reliable methods for quantitatively assessing af®nity and dynamics of the interaction. In particular solid phase detection with immobilized ifnar2-EC seems very useful for a rapid and accurate af®nity screening required for a mutational mapping of the binding site. Additionally, this method can provide a better understanding of the interferon signaling by allowing us to simulate conditions on the cell surface and to monitor the processes at the interface in real time.
Experimental Procedures
Cloning of the extracellular part of the ifnar2 gene into a two-cistron expression vector
The extracellular part of the ifnar2 gene (212 bp) from SYDSP (N-ter) to ESEFS (C-ter; Novick et al., 1994) was ampli®ed by PCR from the plasmid pCEV9 (given to us by M. Rubinstein). Upstream of serine 1 of ifnar2 we added a NdeI restriction site, and downstream the C-terminal serine we added a TAA stop codon, followed by a SalI restriction site. The ifnar2 gene was cloned into a expression vector based on the pT7T3-18U plasmid, to which we added a second cistron just upstream from the starting codon. The second cistron is of the ®rst nine amino acid residues of the lpp 5 H gene, including its SD site¯anked by XbaI and NdeI restriction sites (for details on the sequence of the ®rst cistron, see Schoner et al., 1990) . The reason for inserting a second cistron was to improve the yield of heterologous protein expression (Schoner et al., 1990) . The same protocol was used to construct an expression vector for IFNa2. The new expression vectors are called pT72CR2 (for ifnar2-EC) and pT72Ca2 (for IFNa2).
Expression and purification of recombinant ifnar2-EC from E. coli For protein production, TG1 cells containing the pT72CR2 plasmid were grown at 37 C in 750 ml of 2 Â TY medium containing 100 mg/ml ampicilin in two liter¯asks. At A 600 0.6, protein expression was induced by the addition of 0.2 mM IPTG and infection with M13/T7 phage at an MOI of ®ve plaque forming units per cell (Invitrogen, the phage is expressing the T7 polymerase under the control of a lac promoter). After four hours of additional growth, the cells were pelleted and resuspended in lysis buffer containing 100 mM Tris (pH 8.4), 100 mM NaCl, 1 mM EDTA and lysozyme (50 mg/ml). After sonication, the insoluble fraction was separated by centrifugation and the inclusion bodies were washed with lysis buffer which did not contain lysozyme. Inclusion bodies were dissolved by stirring in 8 M urea for one hour. The denatured protein was refolded by a 20-fold dilution into 100 mM Tris (pH 8.4). The proteins were extracted by adding a cationic ionexchange resin (Q Sepharose R Fast Flow; Pharmacia Biotech) to the solution for one hour and ®ltering the beads on a sintered glass funnel. After intensive washing, the protein was eluted with 0.5 M NaCl. The eluted protein was diluted fourfold and directly applied to an ionexchange column (HiTrap Q, Pharmacia) with a gradient of 0-500 mM NaCl at pH 8.4. Fractions containing major amounts of ifnar2-EC were pooled and further puri®ed by gel ®ltration on a Sephadex R 75 column (16/26) in 50 mM Tris (pH 8.4) and 100 mM NaCl. All puri®cation steps were analyzed by SDS-PAGE under reducing and non-reducing conditions.
Expression and purification of recombinant human IFNa a a2
The gene coding for IFNa2 was cloned into the twocistron expression vector described for ifnar2 yielding the plasmid pT72Ca2. To improve the level of expression, the codons for the ®rst 23 amino acid residues were changed into: TGT GAT CTG CCG CAG ACT CAC TCT CTG GGT TCT CGT CGT ACT CTG ATG CTG CTG GCT CAG ATG CGT CGT. For protein expression, a similar protocol as for ifnar2-EC was followed. IFNa2 was found in the inclusion bodies, which were dissolved in 8 M urea containing 5 mM DTT. IFNa2 was refolded by a 20 fold dilution overnight. Protein puri®cation was carried out as described for ifnar2-EC. Typical yields of protein were 10 mg/l cell culture. IFNa2 runs as a single band of 18 kDa on SDS-PAGE.
Determination of protein concentration
Extinction coef®cients of e 280 26,500 for ifnar2-EC, and e 280 18,070 for IFNa2 were determined by the method by Gill & von Hippel (1989) . Protein concentrations were determined from the UV absorbance at 280 nm using the appropriate extinction coef®cients.
Anti-viral activity of IFNa a a2 and its inhibition by ifnar2-EC
The anti-viral activity of recombinant IFNa2 produced in E. coli was measured by inhibition of the cytopathic effect in human WISH cells using VSV as challenge virus (Rubinstein et al., 1981) , relative to NIH standard IFNb. A binding inhibition assay of IFNa2 anti-viral activity was carried out with ifnar2-EC as follows: 25 units/ml (1.6 Â 10 À12 M) of IFNa2 were mixed with ifnar2-EC in a concentration range of 2.4 Â 10 À10 to 5 Â 10 À7 M and residual IFNa2 anti-viral activity was determined. IFNa2 activity was quanti®ed by measuring the absorbance of light of crystal violet stained WISH cells in the ELISA plate. The corresponding concentration of free IFNa2 was determined by calibration of the IFNa2 activity at eight different concentrations between 5.4 Â 10 À14 M and 1.6 Â 10 À12 M on the same plate. The dissociation constant K d was determined from the titration curve by ®t-ting a simpli®ed model derived from the law of mass action for the case that the concentration of IFNa2 is very small compared to the K d :
where c depicts the free concentration and c 0 the overall concentration of the species IFNa2 (index a2) and ifnar2-EC (index R2).
Analytical gel filtration
Protein purity and activity was monitored by analytical size-exclusion chromatography in a TSKgel QC-PAK GFC 200 column (TosoHaas) and a Superdex R 75 HR10/ 30 column (Pharmacia Biotech). Protein samples of 120 ml with a protein concentration around 1 mM were injected via a 100 ml sample loop. The stoichiometry of the complex was determined by titration with increasing IFNa2 at a constant ifnar2-EC concentration of 1.45 mM. The area under the IFNa2 peak and the double peak of ifnar2-EC and the complex were determined by integration. The contribution of IFNa2 in the complex was calculated from the ifnar2-EC/complex peak by subtracting the area of the original free ifnar2-EC peak. The resulting peak areas were corrected by the extinction coef®cients assuming unchanged absorption of the proteins in the complex, and normalized by the peak areas of the free ifnar2-EC to give relative concentrations. The relative concentration of IFNa2 in the complex peak was plotted versus the relative IFNa2 concentration added in the sample.
Chemical cross-linking
The IFNa2-ifnar2-EC complex was chemically crosslinked with the zero-length cross-linking reagent 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC; Sigma). To 100 ml of a mixture of 8 mM ifnar2-EC and 6 or 12 mM IFNa2 in 10 mM Hepes (pH 7.4) and 100 mM NaCl, 1.5 ml of a freshly prepared 0.2 M aqueous solution of EDC was added. After fast mixing, the solution was incubated for ®ve hours. As a control, a sample which contained either 8 mM recombinant ifnar2-EC or only 12 mM IFNa2 were treated with EDC exactly in the same way. The reaction was stopped by adding 20 ml of 1 M Tris-acetate (pH 7.8) and the samples were analyzed by SDS-PAGE under reducing conditions.
Biomolecular interaction analysis
The interaction between recombinant ifnar2-EC and IFNa2 was monitored by an optical probe called re¯ecto-metric interference spectroscopy (RIfS; Gauglitz et al., 1993) . This method detects biomolecular interaction at interfaces as a change of the apparent optical thickness of a thin silica layer and has been described in detail before (Gauglitz et al., 1993; Schmitt et al., 1997) . Binding to the surface was monitored as a shift in the interference spectrum. A shift of 1 pm corresponds to approximately 1 pg/mm 2 protein on the surface. The transducer surface was modi®ed with a dextran layer (Piehler et al., 1996) and carboxylated by reaction with molten glutaric anhydride (Sigma) at 75 C for two to eight hours. On such surfaces, electrostatic pre-concentration and covalent immobilization of proteins were carried out by standard BIAcore protocols. All measurements were carried out in Analysis of IFN2-Ifnar2 Complex 50 mM Hepes (pH 7.4), 150 mM NaCl and 0.01 % Triton X100. Measurements at different pH were carried out by adjusting the pH of this buffer to avoid possible artifacts due to different buffer ions. A sample volume of 800 ml was injected for 80 seconds, while sampling with a data acquisition rate of 1 Hz. By using¯ow rates up to 50 ml/s, the samples in the¯ow cell were exchanged within one second, allowing for analysis of processes occurring within ten seconds. The binding curves were evaluated with the BIAevaluation software (BIAcore AB, Sweden) using simple one-to-one kinetics models.
SPR measurements were performed on a BIAcore 2000 (BIAcore AB) using a CM5 chip with 300 RU (refractive index units) of active IFNa2 or 50 RU of active ifnar2-EC bound to the surface. Measurement were done under standard conditions in HBS (10 mM Hepes, 3.4 mM EDTA, 150 mM NaCl, 0.05 % surfactant P20, pH 7.4) at 25 C (Cunningham & Wells, 1993; Karlsson et al., 1991) . Af®nity constants were determined by equilibrium titration in solution using the immobilized protein to probe the equilibrium free concentration of the other protein . In these titration experiments, the concentration of free ifnar2-EC was titrated with increasing concentrations of IFNa2 in solution and detected by monitoring the binding to immobilized IFNa2. The initial slopes of these binding curves, which correspond to the free IFNa2 concentration, were determined by an exponential ®t and plotted versus the IFNa2 concentration. The af®nity constant was extracted from these plots by ®tting the precise model according to Piehler et al. (1997) to the data, assuming one-to-one stoichometry of the complex formation:
with the same parameters as de®ned in equation (1).
Stopped-flow measurements
Association rate constants were measured by monitoring de-quenching of tryptophan¯uorescence upon interaction of IFNa2 and ifnar2-EC using a stopped-¯ow setup (Applied Photophysics SX-17MV). The excitation wavelength was 230 nm (Schreiber et al., 1994 ; slit width 1 mm) and emission was monitored using a cutoff ®lter of 320 nm. In each experiment, 400 data points were recorded over a reaction period of one to ®ve seconds (at least ®ve runs were averaged). Pseudo-®rst-order conditions during the interaction were provided by using at least a ®vefold excess of IFNa2. The rates of the interaction k s were determined from an exponential ®t of the data. The association rate constant k on was determined from a plot of k s as a function of the IFNa2 concentration by linear regression.
The electrostatic contributions in the interaction between IFNa2 and ifnar2-EC were determined from association rate constants at salt concentrations between 0.025 M and 0.525 M NaCl. The relation between the electrostatic energy of interaction at the transition state U el and the association rate constant k on is given by: ln k on ln k where k 0 on is the basal rate of association in the absence of electrostatic forces, k is the reciprocal Debye-Hu È ckel screening length and a, which relates to the minimal distance of approach, was ®xed to 6 A Ê . A plot of (1 ka) À1 versus lnk on gives a linear corelation with a slope equal to U el /RT, and an intercept at lnk 0 on (Schreiber & Fersht, 1996; Selzer & Schreiber, 1999; Vijayakumar et al., 1998) .
Linear regression and non-linear least-squares ®tting were done with Kalaidagraph software which calculates the standard error values of the parameters. Standard deviation for multiple measurements were determined using standard equations in Excel 5.0.
